baber/WOPTO huggingface dataset:
Patent NZ-312602-A (NZ)
Title: Control and termination of a battery charging process
Inventor: PODRAZHANSKY YURY M
IPC: B01F7/04
Filed: 1996-07-10
Abstract: A method and an apparatus for adjusting the process of charging a battery so as to charge the battery as rapidly as possible while avoiding overheating of or damage to the battery. The method provides for applying a charging pulse (C1) which provides an average charging current, applying a first depolarizing pulse (D1), waiting for a first rest period (DW1), measuring the voltage (V1) at a predetermined point within the first rest period, applying a second depolarizing pulse (D2), waiting for a second rest period (DW2), measuring the voltage (V2) at the predetermined point within the second rest period, determining a difference between the voltage (V1) and the voltage (V2), and taking corrective action, typically decreasing the average charging current if the difference is greater than a predetermined amount. The present invention also provides for determining whether the battery is low on water.
Patent NZ-326494-A (NZ)
Title: Production of an immunoglobulin enriched fraction from whey protein solutions using a cation exchanger
Inventor: AYERS JOHN STEPHEN
IPC: A23J3/08
Filed: 1997-01-31
Abstract: A process for producing an immunoglobulin enriched whey protein fraction and optionally a whey proteing isolate (WPI) from whey protein solutions is claimed.  The process comprises subjecting a whey protein solution to ion exchange using a cation exchanger at pH 2.5-4.5 under conditions which overload the cation exchanger with potentially adsorbable protein which causes the exchanger to adsorb preferentially whey proteins other than immunoglobulin.  The process further comprises recovering the breakthrough whey protein fraction not adsorbed by the ion exchange step and optionally eluting and recovering the WIP adsorbed to the cation exchange.  An immunoglobulin enriched protein fraction prepared by the process is also claimed.  The whey protein solution may be an ultrafiltration retentate
Patent NZ-331419-A (NZ)
Title: Electrostatic spraying device
Inventor: PRENDERGAST MAURICE JOSEPH
IPC: B05B5/043
Filed: 1997-02-12
Abstract: An electrostatic spraying device as shown comprises a high voltage generating circuit powered by a low voltage circuit comprising one or more radiation sensitive elements and charge storage means.
Patent NZ-332593-A (NZ)
Title: Friction reducing additives for fuels and lubricants
Inventor: CARCY JAMES THOMAS
IPC: C10M133/00
Filed: 1998-01-07
Abstract: Disclosed are hydroxyacetamides that have been prepared by reacting primary etheramines with hydroxycarboxylic acid, particularly etheramine glycolamide, and their use as friction reducing additives in fuels and lubes.
Patent NZ-332696-A (NZ)
Title: Clear, concentrated liquid fabric softener compositions containing quanternary ammonium compounds
Inventor: GRANDMAIRE JEAN-PAUL
IPC: D06M13/02
Filed: 1997-05-28
Abstract: A clear fabric softener aqueous microemulsion concentrate composition capable of conversion to a macroemulsion upon dilution with water comprising: (A) (i) a diester quaternary ammonium surfactant fabric softener selected from the group having the structural formulae as follows: (1) (R")4-n -- N - (R-A)n    A is independently C (O)O-R or -O(O)C-R'; R is a lower alkyl group having 1 to about 4 carbon atoms; R' is an alkyl or alkenyl group having 8 to about 22 carbon atoms; R" is independently a lower alkyl radical having 1 to about 6 carbon atoms or hydroxyl alkyl group or H; n Is an integer having a value of 1 to about 3; and X is a softener compatible anion; and (2) (R")-N-(R)n-(B)2 X-   B Is independently A or (R)n- A: and A, R, R" and n are as defined above; and (3) (R")3-N-(CH2)-R(A)-R(A)X   A R, R" and n are as defined above.
Patent NZ-332893-A (NZ)
Title: Sustained release ionic conjugate containing a biodegradable polymer and a drug
Inventor: IGNATIOUS FRANCIS
IPC: A61K47/48
Filed: 1997-04-22
Abstract: A method of making microparticles of sustained release ionic conjugate containing a free carboxyl group-containing biodegradable polymer and a free amino group-containing drug which are ionically bonded to each other is claimed comprising: a) obtaining a first solution comprising acetone, dichloromethane, acetonitrile, ethyl acetate, tetrahydrofuran or glyme wherein the conjugate is dissolved; b) mixing the first solution with a first liquid to form a first dispersion wherein the first liquid is miscible with the first solution and the conjugate is not soluble in the first liquid and precipitates out of the first dispersion; c) isolating the conjugate from the first dispersion.
Patent NZ-335108-A (NZ)
Title: Methods of inhibiting stem cell proliferation by contacting hematopoietic cells with an inhibiting amount of INPROL
Inventor: KOZLOV VLADIMIR
IPC: C12N5/0789
Filed: 1995-09-29
Abstract: The specification describes the use of INPROL in the preparation of a medicament for inhibiting stem cell proliferation.  INPROL is selected from the group consisting of the alpha chain of hemoglobin, the beta chain of hemoglobin, the gamma chain of hemoglobin, the delta chain of hemoglobin, the epsilon chain of hemoglobin, and the zeta chain of hemoglobin.
Patent NZ-500065-A (NZ)
Title: A condiment dispensing apparatus
Inventor: PHALLEN IVER J
IPC: F04B43/113
Filed: 1998-03-11
Abstract: A condiment dispensing apparatus for dispensing condiments from a bag-in-box type container 108 is claimed.  Support means 106 supports condiment container 108.  A remote point of dispensing fixture 110.1 is claimed.  Pumping means 10 is for pumping the condiment from condiment container 108 to dispensing fixture 110.1 and includes a high durometer compressible elastomeric liquid flow tube 14, an infeed valve assembly 12, an outfeed valve assembly 16 and a discreet extensible and retractable displacement actuating assembly 18 including a movable actuator anvil 26 having a round surface which engages the flow tube 14 at all times.  Pumping means 10 also has a spaced apart top anvil 28 mounted in a location directly opposite from actuator anvil 26.  Top anvil 28 has a round surface in engagement with flow tube 14 at all times.  Flow tube 14 is held between the movable actuating anvil 26 and top anvil 28, in a slightly compressed state when actuating assembly is retracted.   A control means for controlling the operation of pumping means 10 includes a start switch 64 located adjacent dispensing fixture 110.1.  The control means when started sequentially, extends and retracts displacement actuating assembly 18 to cause flow within flow tube 14 from a location adjacent the infeed valve assembly 12 to a location adjacent outfeed valve assembly 16, to cause flow of condiment from the condiment container 108 to the dispensing fixture.   There is a high durometer compressible elastomeric liquid flow tube (14), an infeed and outfeed thereto and therefrom, and a movable anvil (26) with a round surface to compress the tube.  There is an opposed stationary anvil (28) which holds the tube for compression by the movable anvil.  The tube is held between the anvils (26, 28) in a slightly compressed state even when the anvil is retracted.  There is a control assembly (fig. 15) that causes extension and retraction of the movable anvil to cause flow through the tube, and subsequent delivery of condiment to a dispensing fixture (110)
Patent NZ-502419-A (NZ)
Title: Vaporizer and method for extraction of active ingredients from a crude natural product by providing a continuous gas flow which prevents inhalation of larger particles by the user
Inventor: PATE DAVID W
IPC: A61M11/04
Filed: 1998-08-27
Abstract: A vaporiser apparatus (1) and method for uniformly extracting active ingredients of specimen of crude natural product, or inert particulate matrix impregnated with volatile substances without pyrolysis which uses hot air (2), or a heated inert gas stream to volatilise the specimen. The heated air or gas in introduced from below (from either a hot air gun or a high-pressure tank connected to a heat exchanger), and ascends through in most embodiments through a permeable support structure (4) (e.g., fritted glass disk, etc.) subsequently causing specimen particles disposed on the permeable support structure to be suspended within the confines of an isolation chamber (5).
Patent NZ-505573-A (NZ)
Title: Reduction of toxic substances, nitrogen oxides, in waste gas emissions
Inventor: HWANG SHUEN-CHENG
IPC: B01D53/56
Filed: 2000-06-30
Abstract: A process for the removal of pollutants, particularly the reduction or elimination of nitrogen-containing pollutants from gaseous industrial plant effluents.  The process involves contacting the waste gas stream with a nitrogen-based reducing agent at a temperature in the range of 150-1300oC, converting part of the nitrogen oxides to nitrogen.  Remaining nitrogen oxide in the waste is converted to nitric acid and nitric acid precursors by contacting the waste gas with ozone.  The nitric acid and nitric acid precursors are then contacted with an aqueous medium having a pH greater than 7.  The aqueous medium converts the nitric acid and precursors to nitrate salt which are then scrubbed from the waste gas.  Alternatively the process may involve contacting the waste gas with ozone at a temperature of 25-100oC in an aqueous medium at a pH of at least 9 and with the use of a catalyst, tungsten, palladium, platinum, iridium and rhodium, after the initial ozone contact.
Patent NZ-508047-A (NZ)
Title: Fatty acid analogues for the treatment of diabetes
Inventor: BERGE ROLF
IPC: A23L1/30
Filed: 1999-04-23
Abstract: Use of fatty acid analogues of formula CH3(CH2)m(xiCH2)nCOOR, wherein xi is selected from O, S, SO, SO2, Se, CH2, to treat diabetic conditions.
Patent NZ-508073-A (NZ)
Title: Biologically active composition
Inventor: LINDAHL AKE
IPC: A61K9/08
Filed: 1999-05-12
Abstract: A biologically active composition which comprises a biologically active agent to be released therefrom, said biologically active agent being dissolved and/or dispersed in a supersaturated state within a carrier, which carrier comprises a liquid and/or solid non-crystalline ester and/or polyester matrix, and where the precipitation of said biologically active agent is substantially, or completely, inhibited therein. Said supersaturated state is obtainable by subjecting one or more carrier starting substance(s) to such chemical reaction(s) that an ester and/or polyester matrix is provided, the biologically active agent being added after said chemical reaction(s) has (have) been completed.
Patent NZ-512371-A (NZ)
Title: Container with pressure control device for dispensing fluid
Inventor: VLOOSWIJK JOHANNES JACOBUS THO
IPC: B65D83/66
Filed: 1999-12-14
Abstract: Container with pressure control device for maintaining a substantially constant, preset pressure in the container, said container being arranged for dispensing a fluid, the pressure control device comprising a first chamber for containing a pressure fluid, a second chamber in which a control pressure prevails and a third chamber which is formed by or communicates with, or is at least partially accommodated in an inner space of the container, while between the first chamber and the third chamber there is provided a passage opening accommodating a closing member for closing, during normal use, the passage opening when the pressure in the third chamber is lower than the control pressure, a control means being movable by a displaceable or deformable part of the wall of the second chamber and arranged for displacing the closing member at least partially when the pressure in the third chamber is lower than the control pressure, to enable pressure fluid to flow under pressure from the first chamber to the third chamber, at least the control member and/or the second chamber being at least partially removable from the first chamber and biasing means being provided for keeping the closing member in the closed position when at least the control member and/or the second chamber are at least partially removed.
Patent NZ-516173-A (NZ)
Title: Methods for manipulating the avian genome
Inventor: DITULLIO PAUL A
IPC: C07K14/62
Filed: 2000-06-02
Abstract: A method for introducing a nucleic acid molecule into the genome of an avian species, comprising contacting in vivo a blastodermal cell in a laid fertilized egg with an isolated nucleic acid molecule, wherein (a) said nucleic acid molecule is not associated with a viral coat protein, (b) wherein said nucleic acid molecule is introduced directly into the germinal disc of said egg in a volume of greater than 1 microlitre and less than 0.5 millilitres, and (c) said nucleic acid molecule is integrated into a host chromosome of said blastodermal cell, thereby introducing said nucleic acid molecule into the genome of said avian species.
Patent NZ-524011-A (NZ)
Title: Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors
Inventor: BARTLETT JULIE
IPC: A61K31/4184
Filed: 2001-08-31
Abstract: A compound of formula (i); a pharmaceutical composition comprising the compound; and the use of the compound in the manufacture of a medicament for use in the production of a glycogen phosphorylase inhibitory effect in a warm-blooded animal.
Patent NZ-524168-A (NZ)
Title: Use of a thrombolytic agent and an NR2B subtype selective NMDA receptor antagonizing compound in combination for the treatment of stroke and traumatic brain injury
Inventor: CHENARD BERTRAND LEO
IPC: A61K38/49
Filed: 2001-09-05
Abstract: A thrombolytic agent and a NR2B subtype selective NMDA receptor antagonizing compound, wherein the active agents are present in amounts that render the combination of the two agents effective in treating hypoxic or ischemic stroke, are used in the manufacture of a medicament for treating hypoxic or ischemic stroke. Preferably the thrombolytic agent are selected from tissue plasminogen activator (TPA), urokinase, prourokinase and streptokinase.
Patent NZ-525303-A (NZ)
Title: Radiopharmaceuticals that bind chemokine receptor CCR1 are used for diagnosing alzheimer's disease
Inventor: HILGER CHRISTOPH-STEPHAN
IPC: C07D241/04
Filed: 2001-11-01
Abstract: Disclosed herein is the use of radiopharmaceuticals of formula (I) and their salts in diagnosing Alzheimer's disease, that are able to pass through the blood-brain barrier and bind to the chemokine receptor CCR1 present in brain tissue of patients having Alzheimer's disease, wherein: X1 and X2 are each independently halo; R1 and R2 are each independently hydrogen or alkyl; and R3 is hydrogen, amino, monoalkylamino, dialkylamino, monoaralkylamino, alkylcarbonylamino, alkenylcarbonylamino, haloalkylcarbonylamino, arylcarbonylamino, alkoxyalkylcarbonylamino, alkoxycarbonylalkylcarbonylamino, glycinamido, monoalkylglycinamido, arylcarbonylglycinamido, aminocarbonylglycinamido, (aminocarbonyl) (alkyl) glycinamido, (alkoxyalkylcarbonyl) glycinamido, ureido, monoalkylureido, monoarylureido, monoaralkylureido, or alaninamido; and wherein either one of X1 or X2 is selected from the group of 123I, 125I, 128I, 131I, 75Br, 76Br, 80Br, and 18F ; or wherein one of the carbon atoms in the compound is 11C ; or a pharmaceutically acceptable salt thereof.
Patent NZ-527509-A (NZ)
Title: Data exchange between insurer and repairer
Inventor: UREN JOHN
IPC: G06Q10/00
Filed: 2002-02-20
Abstract: A computer system for exchanging data between software applications of an insurer and a repairer, comprises: a message transceiving station, to send messages to and receive messages from the repairer, where each message is one of a closed set comprising a predetermined number of messages and is in the form of data wrapped in syntax to allow it to be mapped into a database structure which obeys relationship constraints and has referential integrity; a message receiver to unpack received messages to retrieve their data content; a message data content parser to parse the data content and write it to tables organized in a predetermined schema in a first database that does not have the relationship constraints and referential integrity; a data collector to extract the data from the first database, validate it and store it in tables organized in the predetermined schema in a second database that does have the relationship constraints and referential integrity.
Patent NZ-528297-A (NZ)
Title: New measuring technique and quantitative analysis of a turbid pharmaceutical sample using spectrometric transmission and/or reflection measurements
Inventor: ABRAHAMSSON CHRISTOFFER
IPC: G01N21/35
Filed: 2002-03-18
Abstract: An apparatus for use in quantitative analysis of a turbid pharmaceutical sample (57), comprises: - means (52) for generating an excitation beam (53) of radiation; - means (50) for intensity modulating the excitation beam (53); -means (54, 55, 56) for focusing the excitation beam (53) onto the sample (57), wherein the means for focusing are parts of a Fourier spectrometer; and - means (58) for detecting all wavelengths simultaneously.
Patent NZ-529768-A (NZ)
Title: Retractable system for stowing away the propulsion components for a vessel
Inventor: PEREZ JAVIER ESCACENA
IPC: B63H5/125
Filed: 2003-11-25
Abstract: A retractable propulsion system for vessels comprises an engine (2) mounted within the hull (1; 101), the drive shaft of which is connected through a universal joint (6) to a propeller shaft (3; 103) which is supported so that it can rotate and slide in a bearing (7; 105) at a point close to the propeller (4; 104). The said bearing (7; 105) is articulated at one end of an extension-retraction mechanism (8, 9; 110, 115, 116, 118) through which the said propeller shaft can be placed in a first operating position outside the hull or a second retracted position in a housing (11, 12; 102, 111) provided in the bottom of the said hull. The said housing is provided with at least one door (13, 13'; 15) which can open to permit the said propeller shaft and the said propeller to pass when the two are moved between the said first and second positions and can close so as to form in that position a surface without any break in continuity in the underside of the said hull. A device for actuating, guiding and locking this system comprises an assembly comprising a pair of upper arms (118, 118') and a pair of lower arms (110, 110') articulated together to form essentially an articulated parallelogram (118, 118'; 110, 110') connected through its upper articulation (116) with actuating means (9; 115) which can be moved vertically and connected through its lower articulation (7a, 17; 109) with the bearing (7; 105) supporting the shaft (3; 103) of the propeller (4; 104) and provided at its lateral articulations with wedge-shaped members (121, 121') designed to bear in a locking relationship against fixing members (113, 113') which are of one piece with the hull (1; 101) of the vessel and grooved (123, 123') in a form corresponding to the said wedge-shaped configuration. The assembly of articulated arms (118, 118'; 10, 110') is locked in the operating position when the upper arms (118, 118') are placed in an over-centring position by the said actuating means (9; 115) once the said lateral members (121, 121') have been coupled to the said fixing members (113, 113').
Patent NZ-530816-A (NZ)
Title: Use of multiple recombination sites with unique specificity in recombinational cloning
IPC: C07K14/47
Filed: 2000-12-11
Abstract: A method of joining two segments of nucleic acid is described that comprises: (a) providing two segments of nucleic acid, each segment comprising at least one recombination site capable of recombining with a recombination site present in the other segment; and (b) contacting the segments with one or more recombination proteins under conditions causing recombination between the recombination site, thereby joining the segments. The method can be the joining of n nucleic acid segments, wherein n is an interger greater than 2 that comprises: (a) providing a 1st through an nth nucleic acid segment, each segment flanked by two recombination sites, wherein the recombination sites are selected such that one of the two recombination sites flanking the ith segment, ni , reacts with one of the recombination sites flanking the ni-lth segment and the other recombination site flanking the ni+lth segment; and (b) contacting the segments with at least one recombination protein under conditions causing the segments to join. It is preferable that at least two nucleic acid segments encode expression products involved in the same biochemical pathway or biological process which can lead to the production of an antibiotic or a carbohydrate. Methods of making a population of recombinant host cells that comprise introducing nucleic acid segments that are joined are also described.
Patent NZ-531211-A (NZ)
Title: Human antibodies specific for interleukin 15 (IL-15)
Inventor: VAN DE WINKEL JAN G J
IPC: A61P1/04
Filed: 2002-08-23
Abstract: Isolated human monoclonal antibodies which specifically bind to IL-15 (e.g., human IL-15), and related antibody-based compositions and molecules, are disclosed. The human antibodies can be produced in a transfectoma or in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, non-human transgenic animals, and hybridomas which produce the human antibodies, and therapeutic methods for using the human antibodies.
Patent NZ-534278-A (NZ)
Title: Brain, spinal and nerve injury treatment
Inventor: NIMMO ALAN JOHN
IPC: A61K38/08
Filed: 2001-01-18
Abstract: Disclosed is the use of a substance P receptor antagonist for the preparation of a medicament for the treatment of brain, spinal cord and nerve injury, for the improvement of cognitive outcome after brain injury, for preventing substance P induced deficits in learning and memory after brain injury, for the improvement of motor and cognitive outcome in mild to severe brain injury, the reduction of blood brain barrier permeability, for the reduction of formation of vasogenic oedema or for the prevention of acute water accumulation in the brain after injury. (62) Divided out of 519990
Patent NZ-535592-A (NZ)
Title: 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
Inventor: GRAVESTOCK MICHEAL BARRY
IPC: A61P31/04
Filed: 2003-02-25
Abstract: Disclosed are compounds of formula (I), wherein: -N-HET is (Id) or (If), R1 is an alkyl group, Q is Q1 or Q2, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for use as antibiotics.
Patent NZ-536178-A (NZ)
Title: Epothilone derivative for the treatment of hepatoma and other cancer diseases
Inventor: ROTHERMEL JOHN DAVID
IPC: A61K31/425
Filed: 2003-04-30
Abstract: Disclosed is a use of an epothilone derivative of formula (I) in the manufacture of a medicament for the treatment of a cancer disease selected from hepatoma; primary fallopian tube cancer; primary peritoneal cancer; renal cell carcinoma progressing after treatment with a cytokine; radiotherapy and/or nephrectomy; ovarian cancer progressing after treatment with a platinum compound or radiotherapy; and colorectal cancer progressing after radiotherapy and/or treatment with oxaliplatin or irinotecan; and metastasis thereof.
Patent NZ-536487-A (NZ)
Title: Animal drying apparatus with planar flow of compressed air to entire side of animal passing through apparatus
Inventor: SIGNAL JOHN RUSSELL
Filed: 2004-11-10
Abstract: Air knives 19 direct compressed air to an animal (not shown) passing on conveyor 13. This is stated to have the effect of drying an entire side of the animal (typically a sheep prior to slaughter).